Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
Huntington Ingalls Industries heads into its October 29 earnings report with short interest rising sharply, analysts cutting targets, and the stock down 8% over the past month.
The most striking positioning development is the speed of the short interest rebuild. Short sellers added meaningfully to positions over the past week, with SI rising 18.8% in seven days to reach 3.7% of free float. Over the past month the position has grown nearly 48%. That pace of accumulation, from roughly 990,000 shares short in early September to 1.46 million today, is notable for a defense name with an otherwise clean lending market. Availability is extremely loose at 4,651%, meaning there is abundant capacity for new shorts to enter, and cost to borrow remains low at 0.41%. Nothing in the borrow market suggests a squeeze is forming. This is a deliberate directional bet, not a technical overhang.
Options tell a different story. The put/call ratio has been declining steadily over the past three weeks, dropping from above 1.0 in late September to 0.81 today, about one standard deviation below its 20-day average. Call activity is running higher than it has been, which sits oddly against the rising short interest. That divergence, shorts rebuilding while options traders lean toward calls, makes the setup genuinely ambiguous rather than cleanly bearish.
On the Street, the direction of travel is unmistakably lower for price targets, even where conviction on the rating holds. Bernstein cut its target this week to $304, the second reduction in less than a month from the same analyst, while maintaining a Market Perform. TD Cowen, which holds a Buy, trimmed to $340 from $360 just days ago. The mean analyst target sits at $356, implying more than 38% upside from the current price of $257.84. That gap is large, but it reflects a stock that has been re-rated steadily downward since early 2026, with targets that were above $400 earlier in the year now clustered in the $300 to $380 range. The company scores well on earnings surprise history (84th percentile) and carries a top-percentile dividend score of 99. At a PE of 12.6x and EV/EBITDA of 10.3x, both of which have contracted over the past 30 days, valuation is undemanding for a defence name, but the market appears to be pricing ongoing execution risk rather than rewarding it.
The institutional register is stable and index-heavy, with BlackRock, State Street and various Vanguard vehicles holding the top positions. None of the 13D/G filings indicate an activist presence. The recent insider activity carries a routine character: ten directors each received 177 shares on October 1 as a compensation award, a scheduled grant rather than a signal of discretionary conviction. On net, insiders have sold roughly $4.5 million worth of shares over the past 90 days.
Earnings history provides one compelling data point. The July 30 quarterly print produced a 16.4% single-day gain and a 14.8% gain over the five days that followed, a result that clearly wrong-footed the shorts who had been building positions through early summer. Whether the October print produces a repeat or a reversal is the question the divergence between rising shorts and call-heavy options leaves unresolved. The ORTEX short score has edged up to 35.6 from 33.1 a week ago, a modest uptick rather than an alarm signal.
What to watch: the Oct 29 print is less about whether HII can continue to grow revenue and more about whether management updates guidance on its shipbuilding schedules and whether cost pressures at Newport News and Ingalls remain contained. The short sellers who have rebuilt positions over the past six weeks are taking a view that the July beat was the exception, not the pattern.
See the live data behind this article on ORTEX.
Open HII on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
